OR OR 500 mg orally 2x/day for 7 days One 5 g applicator intravaginally 1x/day for 5 days One 5 g applicator intravaginally at bedtime for 7 days tinidazole 2 g orally 1x/day for 2 days tinidazole 1 g orally 1x/day for 5 days clindamycin 300 mg orally 2x/day for 7 days clindamycin ovules 100 mg intravaginally at bedtime for 3 days OR OR OR Treatment is recommended for all symptomatic pregnant women. 2 g IV every 12 hours 100 mg orally or IV every 12 hours 2 g IV every 6 hours 100 mg orally or IV every 12 hours 250 mg IM in a single dose 100 mg orally twice a day for 14 days 500 mg orally twice a day for 14 days 2 g IM in a single dose 1 g orally administered concurrently in a single dose 100 mg orally twice a day for 14 days 500 mg orally twice a day for 14 days 
Cervicitis

Parenteral Regimen
Sexually Transmitted Diseases: Summary of 2015 CDC Treatment Guidelines
These summary guidelines reflect the 2015 CDC Guidelines for the Treatment of Sexually Transmitted Diseases. They are intended as a source of clinical guidance. An important component of STD treatment is partner management. Providers can arrange for the evaluation and treatment of sex partners either directly or with assistance from state and local health departments. Complete guidelines can be ordered online at www.cdc.gov/std/treatment or by calling 1 (800) CDC-INFO (1-800-232-4636).
The complete list of recommended regimens can be found in CDC's 2015 STD Treatment Guidelines.
Consider concurrent treatment for gonococcal infection if at risk of gonorrhea or lives in a community where the prevalence of gonorrhea is high. Presumptive treatment with antimicrobials for C. trachomatis and N. gonorrhoeae should be provided for women at increased risk (e.g., those aged <25 years and those with a new sex partner, a sex partner with concurrent partners, or a sex partner who has a sexually transmitted infection), especially if follow-up cannot be ensured or if NAAT testing is not possible.
